Cyrille Drouot

Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis

Thierry Bordet, Bruno Buisson, Magali Michaud et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 251 citations

Life Sciences, Neuroscience, Pharmacology +17

Identification of Key Residues for Interaction of Vasoactive Intestinal Peptide with Human VPAC1 and VPAC2Receptors and Development of a Highly Selective VPAC1Receptor Agonist

Pascal Nicole, Laurence Lins, Christiane Rouyer‐Fessard et al. · Journal of Biological Chemistry · 2000 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

TRO40303, a New Cardioprotective Compound, Inhibits Mitochondrial Permeability Transition

Sophie Schaller, Stéphanie Paradis, Gladys A. Ngoh et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 116 citations

Medicine, Cardiology, Pharmacology +17

GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functions

Sonia Brun, Eloïne Bestion, Éric Raymond et al. · Autophagy · 2021 · 86 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Tof-SIMS Analysis of Polymer Bound Fmoc-protected Peptides

Cyrille Drouot, Christine Enjalbal, P. Fulcrand et al. · Tetrahedron Letters · 1997 · 20 citations

Natural Sciences, Biochemistry, Chemistry +11